Your browser is out of date

With an updated browser, you will have a better Medtronic web site experience. Update my browser now.

×

Menu
United States of America
United States of America
Contact & Support

AN INNOVATIVE TREATMENT option for painful BONE Metastases

Talk to a Medtronic Rep to learn how the clinically demonstrated
OsteoCool™ radiofrequency ablation system can help
patients achieve pain relief and improved quality of life
for those with bone metastases.

DOWNLOAD BROCHURE(opens new window)
Alert Indications, Safety, and Warnings (opens new window)

The OsteoCool™ radiofrequency ablation system is internally-cooled radiofrequency (RF) ablation technology. This innovative therapy offers a minimally invasive, palliative option for patients suffering from painful bone tumors. The OsteoCool™ procedure does not disrupt systemic therapies and can be used before and after radiation therapy.

 

NEW 12-MONTH OPUS ONE DATA—CLINICALLY DEMONSTRATED PAIN RELIEF AND IMPROVED QUALITY OF LIFE

SWIFT, SIGNIFICANT, SUSTAINED PAIN relief
and improved
quality of life

The multicenter OsteoCool™ Post-Market Clinical Study (OPuS One) is the largest, prospective study in RF ablation for bone metastases.1-3 Outcomes in 206 patients treated demonstrated swift, significant and sustained pain relief and improved quality of life at just 3 days post procedure, sustained out to 12 months.
see the data

Hear from your peers

Jason Levy, M.D., and Amir Lavaf, M.D., DABR, give their multidisciplinary perspectives on the clinical evidence and approaches for treating bone metastases.
1

Levy J, Hopkins T, Morris J, et al. Abstract No. 346. Radiofrequency ablation for the palliative treatment of bone metastases: outcomes from a multicenter study in 100 patients. J Vasc Intervent Radiol. 2020;31(3 Supplement):S158. doi: https://doi.org/10.1016/j.jvir.2019.12.404

2

Levy J, David E, Hopkins T, et al. Radiofrequency Ablation for the Palliative Treatment of Osseous Metastases: Final Results from a Multicenter Study (OPuS One). Abstract at Society for Interventional Radiology Annual Scientific Meeting. Virtual. 2021.

3

Levy J, David E, Hopkins T, et al. Improvement In Quality Of Life In Patients Treated For Painful Osseous Metastases With Radiofrequency Ablation: The Opus One Study. Abstract at Society for Interventional Radiology Annual Scientific Meeting. Virtual. 2021.

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

Your information will be used and protected in accordance with our {link}

There are items that require your attention.
United States

Customer Care Team

Hours: 8:00 a.m. - 8:00 p.m. EST 

 

Phone: 763-514-4000

Toll-free: 800-633-8766

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

OR

There are items that require your attention.

OR

There are items that require your attention.
There are items that require your attention.

OR

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

OR

There are items that require your attention.

Before we get started, what best describes you?

OR

There are items that require your attention.

OR

OR

There are items that require your attention.

Before we get started, what best describes you?

OR

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

Your personal data will be used to manage your relationship with Medtronic in accordance with our {link}

There are items that require your attention.

Before we get started, what best describes you?

OR

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

If you consent to receive emails, you can unsubscribe anytime via the link in each email. We use technology that measures email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}